24 results on '"Eshel, Rinat"'
Search Results
2. Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series
3. Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study
4. Combined plerixafor and granulocyte colony-stimulating factor for harvesting high-dose hematopoietic stem cells: Possible niche for plerixafor use in pediatric patients
5. Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series
6. Acute myeloid leukemia with 11q23/MLL rearrangement after ‘FCR’ regimen for chronic lymphocytic leukemia
7. Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myeloma
8. Significant correlation between peripheral blood CD34+ cell count in children prior to aphaeresis and CD34+ cell yield following aphaeresis: A single-center experience
9. Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study.
10. Correlation Between Pre-Collection CD34 Blood Concentrations and CD34 Collection Yield in Difficult-to-Mobilize Patients Given Plerixafor: A Retrospective Single Center Study
11. Unexpected detection of monoclonal B‐cell lymphocytosis in a HLA‐matched sibling donor on the day of allogeneic stem cell transplantation for a patient with chronic lymphocytic leukaemia: clinical outcome
12. HLA-Identical Dendritic-Leukemic Cell Hybrids Generate Specific CTLs in Vitro
13. Highly Sensitive Patient-Specific Real-Time PCR SNP Assay for Chimerism Monitoring after Allogeneic Stem Cell Transplantation
14. Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells
15. Generation of Human Anti-Leukemia CTL Vaccine Utilizing Dendritic Cell Hybrids.
16. Receptors involved in microenvironment-driven molecular evolution of cancer cells
17. Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells
18. The FX Enzyme Is a Functional Component of Lymphocyte Activation
19. The GPI-linked Ly-6 Antigen E48 Regulates Expression Levels of the FX Enzyme and of E-selectin Ligands on Head and Neck Squamous Carcinoma Cells
20. Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress
21. Microenvironmental factors regulate Ly-6 A/E expression on Py V-transformed BALB/c 3T3 cells
22. AN association between high Ly‐6A/E expression on tumor cells and a highly malignant phenotype
23. JAK2 Mutation: An Aid in the Diagnosis of Occult Myeloproliferative Neoplasms in Patients with Major Intraabdominal Vein Thrombosis and Normal Blood Counts.
24. Acute myeloid leukemia with 11q23/ MLL rearrangement after ' FCR' regimen for chronic lymphocytic leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.